Renaissance Group LLC Shockwave Medical, Inc. Transaction History

Renaissance Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$191.17 - $325.63 $475,822 - $810,493	2,489 Added 25.75%	12,156 $3.96 Million
Q4 2023 Feb 09, 2024	BUY	$160.99 - $215.69 $42,340 - $56,726	263 Added 2.8%	9,667 $1.84 Million
Q3 2023 Nov 13, 2023	BUY	$194.33 - $283.97 $30,509 - $44,583	157 Added 1.7%	9,404 $1.87 Million
Q2 2023 Aug 10, 2023	BUY	$223.05 - $302.68 $109,963 - $149,221	493 Added 5.63%	9,247 $2.64 Million
Q1 2023 May 12, 2023	BUY	$175.41 - $217.92 $122,085 - $151,672	696 Added 8.64%	8,754 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $29,021 - $42,148	142 Added 1.79%	8,058 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $33,966 - $54,032	174 Added 2.25%	7,916 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $897,375 - $1.66 Million	7,742 New	7,742 $1.48 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.